Incidence of primary skin cancer after organ transplantation: An 18-year single-center experience in Korea - 14/02/14
, Jee Ho Choi, MD, PhD a, Kee Chan Moon, MD, PhD a, Duck Jong Han, MD, PhD b, Su Kil Park, MD, PhD c, Jae-Joong Kim, MD, PhD d, Jae Won Lee, MD, PhD e, Sung-Gyu Lee, MD, PhD bAbstract |
Background |
Skin cancer is the most common malignancy to arise after organ transplantation in Caucasians, but limited data are available on its incidence in Asian transplant recipients.
Objective |
We sought to assess the incidence of skin cancer after organ transplantation in a Korean cohort.
Methods |
A cohort study was conducted to determine the incidence and risk factors for skin cancers among kidney, liver, heart, or pancreas transplant recipients, treated at the Asan Medical Center in Seoul, Korea.
Results |
The cumulative incidences of skin cancer were 0.70% at 5 years, 1.66% at 10 years, and 2.31% at 15 years. For all skin cancers, squamous cell carcinoma, basal cell carcinoma, and Kaposi sarcoma, the standardized incidence ratios between the recipients and the Korean general population were 30.9 (95% confidence interval, 12.4-63.6), 61.9 (12.8-180.8), 11.9 (0.3-66.1), and 565.2 (68.4-2041.6) after the end of the fifth posttransplantation year, respectively.
Limitations |
We cannot exclude the possibility of both the underestimation because of potential missing cases and the overestimation because of the ascertainment bias.
Conclusion |
The incidence of posttransplantation skin cancer is very low in Korean patients. However, the risk of skin cancer in organ transplant recipients may be considerably higher than that in the Korean general population.
Le texte complet de cet article est disponible en PDF.Key words : Asian, immunosuppression, incidence, Korean, skin cancer, transplantation
Abbreviations used : BCC, CIS, KS, SCC, SIR
Plan
| Drs G-H. Park and S. E. Chang contributed equally to this work. |
|
| Funding sources: This work was supported by Korean Science Ministry 2011-0409 and partially supported by Asan Life Science institue 2011-415. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 70 - N° 3
P. 465-472 - mars 2014 Retour au numéro
Article précédent
- Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients
- Anne Kricker, Bruce Armstrong, Vibeke Hansen, Alan Watson, Gurpreet Singh-Khaira, Christophe Lecathelinais, Chris Goumas, Afaf Girgis
- Tanning addiction and psychopathology: Further evaluation of anxiety disorders and substance abuse
- Lisham Ashrafioun, Erin E. Bonar
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?